Lim Hyunyoung, Lee Suk-Koo, Kim Gaabsoo
Department of Anesthesiology and Pain Medicine, Hanyang University Medical Center.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine.
Tohoku J Exp Med. 2017 Nov;243(3):179-186. doi: 10.1620/tjem.243.179.
Carbon monoxide (CO) and nitrogen oxide (NO) affect vasodilation and cause hemodynamic change. Hemodynamic instability due to liver transplantation may result in poor prognosis of graft. This study investigated the hemodynamic implications of CO and NO levels measured using carboxyhemoglobin (COHb) and methemoglobin (MetHb) during living donor liver transplantation (LDLT). The hemodynamic instability with a pressor dose (norepinephrine equivalent) was estimated 1 hour after graft reperfusion. COHb and MetHb were used as indexes of CO and NO, and were measured using an arterial blood gas analyzer. One hundred and ten recipients who underwent LDLT from May 2011 to July 2013 were selected. Recipients were divided into high (≥ 1.9%) and low (< 1.9%) COHb groups with COHb concentrations at 5 minutes after reperfusion. Recipients were also divided into high (≥ 0.4%) and low (< 0.4%) MetHb groups with MetHb concentrations at 30 minutes after reperfusion. Data are presented as mean ± standard deviation or number (percentage). Model for End-stage Liver Disease (MELD) scores were different for the two COHb groups (low: 13.4 ± 9.0 vs. high: 19.7 ± 10.6, p < 0.001), and pressor doses adjusted by MELD scores were also different between the two COHb groups (low: 0.09 ± 0.01 μg/kg/min vs. high: 0.14 ± 0.01 μg/kg/min, p = 0.029). By contrast, pressor doses and MELD scores were not different between the two MetHb groups. In conclusion, CO rather than NO has hemodynamic implications during LDLT. Therefore, the increase in COHb during LDLT is predictive of hemodynamic instability.
一氧化碳(CO)和氮氧化物(NO)会影响血管舒张并导致血流动力学变化。肝移植引起的血流动力学不稳定可能导致移植物预后不良。本研究调查了在活体肝移植(LDLT)期间使用羧基血红蛋白(COHb)和高铁血红蛋白(MetHb)测量的CO和NO水平对血流动力学的影响。在移植物再灌注1小时后,评估使用升压剂量(去甲肾上腺素当量)时的血流动力学不稳定情况。将COHb和MetHb用作CO和NO的指标,并使用动脉血气分析仪进行测量。选取了2011年5月至2013年7月接受LDLT的110名受者。根据再灌注后5分钟时的COHb浓度,将受者分为高(≥1.9%)和低(<1.9%)COHb组。根据再灌注后30分钟时的MetHb浓度,将受者也分为高(≥0.4%)和低(<0.4%)MetHb组。数据以平均值±标准差或数量(百分比)表示。两个COHb组的终末期肝病模型(MELD)评分不同(低:13.4±9.0 vs. 高:19.7±10.6,p<0.001),并且经MELD评分调整后的升压剂量在两个COHb组之间也不同(低:0.09±0.01μg/kg/min vs. 高:0.14±0.01μg/kg/min,p = 0.029)。相比之下,两个MetHb组之间的升压剂量和MELD评分没有差异。总之,在LDLT期间,是CO而非NO对血流动力学有影响。因此,LDLT期间COHb的升高可预测血流动力学不稳定。